Moffitt Cancer Center and Deerfield Management Launch Bayfield Therapeutics

Moffitt Cancer Center, one of the nation’s leading cancer care and research institutions, and Deerfield Management, a healthcare investment firm, announced today a major translational research alliance to accelerate the development of new therapeutics to treat cancer. Through a newly launched company called Bayfield Therapeutics LLC, Deerfield has committed up to $130 million over the next 10 years to this new collaboration.